Advertisement
Research Article| Volume 147, ISSUE 1, P147-153, November 1999

The effect of menopause on blood lipid and lipoprotein levels

      Abstract

      There is increasing evidence from epidemiological studies that exogenous estrogen (hormone replacement therapy) protects against the elevated risk of cardiovascular disease in women after the menopause. However, it is still uncertain whether the postmenopausal decrease in endogenous estrogen in itself contributes significantly to this increase in risk. Most of the studies that have provided evidence linking cardiovascular disease with menopause have involved North American women, who may differ significantly from Europeans in terms of lifestyle and diet. ICARUS (Italian Climacteric Research Group Study) is an observational study that involves Italian Menopause Clinics, with the objective of collecting observational data on menopause and its management. The results of a cross-sectional analysis of 9309 women, free from any hormonal treatment and enrolled up to March 1997, are reported here. Data show that the menopause has a marked effect on the circulating levels of lipids and lipoproteins. From pre- to post-menopause there are significant increases in total cholesterol (6.9% before and 4.4% after adjustment for covariates including chronological age, educational level, center, BMI, smoking habits, hypertension and diabetes, previous contraceptive use, and time since menopause), LDL (7.5% before, 4.0% after), and triglycerides (9.0% before, 3.2% (ns) after). However, there is no significant change in HDL. Among postmenopausal women, no effect on lipid profile of time since menopause was observed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gordon T.
        • Kannel W.B.
        • Hjortland M.C.
        • McNamara P.M.
        Menopause and coronary heart disease. The Framingham Study.
        Ann. Intern. Med. 1978; 89: 157-161
        • Witteman J.C.
        • Grobbee D.E.
        • Kok F.S.
        • Hofman A.
        • Valkenburg H.A.
        Increased risk of atherosclerosis in women after the menopause.
        Br. Med. J. 1989; 298: 642-644
        • Barrett-Connor E.
        • Bush T.L.
        Estrogen and coronary heart disease in women.
        J. Am. Med. Assoc. 1991; 265: 1861-1867
        • Barrett-Connor E.
        • Grady D.
        Hormone replacement therapy, heart disease and other considerations.
        Annu. Rev. Public Health. 1998; 19: 55-72
        • Stampfer M.J.
        • Colditz G.A.
        Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence.
        Prev. Med. 1991; 20: 47-63
        • Kovanen P.T.
        • Brown M.S.
        • Goldstein J.C.
        Increased binding of low density lipoproteins to liver membranes from rats treated with 17 alpha ethinyl estradiol.
        J. Biol. Chem. 1979; 254: 11367-11373
        • Wild R.A.
        • Taylor E.L.
        • Knehans A.
        The gynecologist and the prevention of cardiovascular disease.
        Am. J. Obstet. Gynecol. 1995; 172: 1-13
        • Barrett-Connor E.
        • Wenger N.K.
        • Grady D.
        • Mosca L.
        • Collins P.
        • Kornitzer M.
        • Cox D.A.
        • Moscarelli E.
        • Anderson P.W.
        Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
        Maturitas. 1998; 31: 1-7
        • Barrett-Connor E.
        The menopause, hormone replacement, and cardiovascular disease: the epidemiological evidence.
        Maturitas. 1996; 23: 227-234
        • Warnick G.R.
        • Albers J.J.
        A comprehensive evaluation of the heparin manganese precipitation procedure for estimating high density lipoprotein cholesterol.
        J. Lipid Res. 1978; 19: 65-76
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson P.S.
        Estimation of the concentration of low density lipoprotein in plasma without the use of the preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499-502
        • Barrett-Connor E.
        Postmenopausal estrogen and prevention bias.
        Ann. Intern. Med. 1991; 115: 455-456
        • Stevenson J.C.
        • Crook D.
        • Godsland I.F.
        Influence of age and menopause on serum lipids and lipoproteins in healthy women.
        Atherosclerosis. 1993; 98: 83-90
        • Jensen J.
        • Nilas L.
        • Christiansen C.
        Influence of menopause on serum lipids and lipoproteins.
        Maturitas. 1990; 12: 321-331
        • Matthews K.A.
        • Meilahn E.
        • Kuller L.H.
        • Kelsey S.F.
        • Caggiula A.W.
        • Wing R.R.
        Menopause and risk factors for coronary heart disease.
        N. Engl. J. Med. 1989; 7: 641-646
        • Pansini F.
        • Bonaccorsi G.
        • Calisesi M.
        • Campobasso C.
        • Franze G.P.
        • Gilli G.
        • Locorotondo G.
        • Mollica G.
        Influence of spontaneous and surgical menopause on atherogenic metabolic risk.
        Maturitas. 1993; 17: 181-190
        • Fukami K.
        • Koike K.
        • Hirota K.
        • Yoshikawa H.
        • Miyake A.
        Perimenopausal changes in serum lipids and lipoproteins: A 7-year longitudinal study.
        Maturitas. 1995; 22: 193-197
        • Poehlman E.T.
        • Toth M.J.
        • Ades P.A.
        • Rosen C.J.
        Menopause associated changes in plasma lipids, insulin-like growth factor 1 and blood pressure: a longitudinal study.
        Eur. J. Clin. Invest. 1997; 27: 322-326
        • Kuller L.H.
        • Gutai J.P.
        • Meilahn E.
        • Matthews K.A.
        • Plantinga P.
        Relationship of endogenous sex hormones to lipids and apoproteins in postmenopausal women.
        Arteriosclerosis. 1990; 10: 1058-1066
        • Grundy S.M.
        Comparison of mono-unsaturated fatty acids and carbohydrates for lowering plasma cholesterol.
        N. Engl. J. Med. 1986; 314: 745-748
        • Mensink R.P.
        • Katan M.B.
        Effect of mono-unsaturated fatty acids versus complex carbohydrates on high density lipoproteins in healthy men and women.
        Lancet. 1987; 1: 122-125
        • Sirtori C.R.
        • Tremoli E.
        • Gatti E.
        • et al.
        Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high risk patients.
        Am. J. Clin. Nutr. 1986; 44: 635-642
        • Anderson A.J.
        • Sobocinksi K.A.
        • Freeman D.S.
        • Barboriak J.J.
        • Rimm A.A.
        • Gruchow H.W.
        Body fat distribution, plasma lipids and lipoproteins.
        Arteriosclerosis. 1988; 8: 88
        • Despres J.P.
        • Allard C.
        • Tremblay A.
        • Talbot J.
        • Bouchard C.
        Evidence for a regional component of body fatness in the association with serum lipids in men and women.
        Metabolism. 1985; 34: 967